Trial Profile
Safety and efficacy of Absorb bioresorbable scaffold (ABS) for the treatment of complex coronary disease: A real-world experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 17 Dec 2015 New trial record